Biomarker Assessments of Leukine During Treatment of Parkinson's Disease

NCT03790670 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

7

Enrollment

OTHER

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: sargramostim

Sponsor

University of Nebraska